Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,448.50p on 02-05-2025 at 18:05:05
Change -14.50p -0.99%
Buy 1,450.00p
Sell 1,449.00p
Buy / Sell GSK Shares
Last Trade: Buy 137,045.00 at 1,455.00p
Day's Volume: 7,904,151
Last Close: 1,448.50p
Open: 1,450.00p
ISIN: GB00BN7SWP63
Day's Range 1,447.00p - 1,478.00p
52wk Range: 1,242.50p - 1,820.00p
Market Capitalisation: £58,918m
VWAP: 1,458.45493p
Shares in Issue: 4,068m

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 137,045 1,455.00p Suspected BUY Trade
17:03:31 - 02-May-25
Buy* 1,000 1,448.50p SI Trade
Negotiated Trade
16:48:52 - 02-May-25
Buy* 2,721 1,448.50p Automatic Execution
16:35:37 - 02-May-25
Buy* 150 1,448.50p Automatic Execution
16:35:30 - 02-May-25
Buy* 5,160 1,448.50p Automatic Execution
16:35:20 - 02-May-25
Buy* 2,580 1,448.50p Automatic Execution
16:35:16 - 02-May-25
Buy* 7,740 1,448.50p Automatic Execution
16:35:15 - 02-May-25
Unknown* 26,628 1,448.50p OTC Trade
16:35:15 - 02-May-25
Unknown* 3,942 1,448.50p OTC Trade
16:35:15 - 02-May-25
Unknown* 625 1,448.50p OTC Trade
16:35:15 - 02-May-25
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd May 2025 (Fri) 1,450.00 1,478.00 1,447.00 1,448.50 7,904,151
1st May 2025 (Thu) 1,468.50 1,479.50 1,450.50 1,463.00 5,517,712
30th Apr 2025 (Wed) 1,450.50 1,505.50 1,427.50 1,483.50 15,144,377
29th Apr 2025 (Tue) 1,426.50 1,435.50 1,404.50 1,432.00 9,850,866
28th Apr 2025 (Mon) 1,396.00 1,413.50 1,394.00 1,409.00 5,334,790
25th Apr 2025 (Fri) 1,394.00 1,397.50 1,381.50 1,389.00 7,503,969
24th Apr 2025 (Thu) 1,392.50 1,394.00 1,373.00 1,394.00 9,805,258
23rd Apr 2025 (Wed) 1,370.00 1,389.00 1,360.50 1,379.00 11,614,238
22nd Apr 2025 (Tue) 1,351.00 1,363.00 1,329.50 1,362.00 15,058,162
21st Apr 2025 (Mon) 1,336.50 1,336.50 1,336.50 1,336.50 0
18th Apr 2025 (Fri) 1,336.50 1,336.50 1,336.50 1,336.50 0
17th Apr 2025 (Thu) 1,332.00 1,338.00 1,314.00 1,336.50 26,508,562
16th Apr 2025 (Wed) 1,335.50 1,352.00 1,327.00 1,345.50 6,577,953
15th Apr 2025 (Tue) 1,327.00 1,354.50 1,326.00 1,346.00 7,276,841
14th Apr 2025 (Mon) 1,314.50 1,328.50 1,305.00 1,322.50 9,808,841
11th Apr 2025 (Fri) 1,279.50 1,300.00 1,268.00 1,294.00 21,358,480
10th Apr 2025 (Thu) 1,324.00 1,336.00 1,275.00 1,275.00 17,009,281
9th Apr 2025 (Wed) 1,295.50 1,308.50 1,242.50 1,264.00 19,853,546
8th Apr 2025 (Tue) 1,337.50 1,361.50 1,325.00 1,340.50 17,966,374
7th Apr 2025 (Mon) 1,377.50 1,380.00 1,324.00 1,331.50 20,249,601
4th Apr 2025 (Fri) 1,459.50 1,469.00 1,413.00 1,417.50 10,583,728
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
2nd May 2025 7:00 am RNS Transaction in Own Shares
1st May 2025 3:30 pm RNS Director/PDMR Shareholding
1st May 2025 3:00 pm RNS Total Voting Rights
1st May 2025 7:00 am RNS Nucala MATINEE data in COPD published in NEJM
1st May 2025 7:00 am RNS Transaction in Own Shares
30th Apr 2025 7:05 am RNS Transaction in Own Shares
30th Apr 2025 7:00 am RNS 1st Quarter Results
29th Apr 2025 7:00 am RNS Transaction in Own Shares
28th Apr 2025 7:00 am RNS Transaction in Own Shares
25th Apr 2025 7:00 am RNS Transaction in Own Shares
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: FTSE 100 stutters despite fresh tech-led US gains

1st May 2025 17:03

(Alliance News) - The FTSE 100 edged higher on Thursday, extending its best winning run since 2017, supported by tech-inspired gains on Wall Street. Read More

LONDON BROKER RATINGS: Deutsche Bank, Deutsche Numis raise GlobalData

1st May 2025 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON BRIEFING: FTSE 100 called green following Ukraine minerals deal

1st May 2025 07:47

(Alliance News) - London stocks were called to open higher on Thursday, ahead of the manufacturing purchasing managers' index read for the UK. Read More

IN BRIEF: GSK highlights positive results from Nucala trial

1st May 2025 07:45

GSK PLC - London-based pharmaceutical maker - Says trial of Nucala, whose generic name is mepolizumab, shows positive results in the treatment of chronic obstructive pulmonary disease. The results shows a 21% reduction in the annualised rate of moderate-to-severe exacerbations in a wide COPD population. The study assesses mepolizumab, a monoclonal antibody that targets interleukin-5, in a variety of COPD patients. Nucala is not yet approved for the treatment of COPD in any country, but regulatory submissions are under review in several countries, GSK says, including the US, China and the EU. Read More

LONDON MARKET CLOSE: FTSE 100 up but US markets slip on soft GDP data

30th Apr 2025 17:17

(Alliance News) - The FTSE 100 closed higher on Wednesday, as US markets fell after weak economic growth data. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value8,596.35
Change99.55

Login to your account

Forgot Password?

Not Registered